A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease.
Inflammatory bowel diseases.
Times cited: 81
- A study to determine the nitroglycerin ointment dose and dosing interval that best promote the healing of chronic anal fissures. Diseases of the colon and rectum. 2002 Academic Article GET IT